The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 19, 2022
Filed:
Jul. 14, 2020
Applicant:
Idorsia Pharmaceuticals Ltd., Allschwil, CH;
Inventors:
Hamed Aissaoui, Allschwil, CH;
Philippe Guerry, Allschwil, CH;
Francois Lehembre, Allschwil, CH;
Julien Pothier, Allschwil, CH;
Laetitia Pouzol, Allschwil, CH;
Sylvia Richard-Bildstein, Allschwil, CH;
Shuguang Yuan, Allschwil, CH;
Assignee:
IDORSIA PHARMACEUTICALS LTD., Allschwil, CH;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/14 (2006.01); C07D 413/12 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 417/14 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); A61P 35/00 (2018.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 413/12 (2013.01); C07D 417/14 (2013.01); C07B 2200/07 (2013.01); C07B 2200/09 (2013.01);
Abstract
The present invention relates to piperidine derivatives of formula (I) wherein Ar, Ar, R, R, R, and Rare as described in the description, their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as CXCR7 receptor modulators.